Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 4,415.00
+15.00 (0.34%)
Nov 4, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 24.41 billion as of November 4, 2026. It is the 37,532nd most valuable company in the world and the 2,280th biggest in South Korea. Its market cap has decreased by 50.06% in one year.
Market Cap
24.41B
Enterprise Value
10.55B
Revenue
32.90B
Global Rank
Country Rank
#2,280 South Korea
PE Ratio
4.53
ChartMarket Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 24.41B, a decrease of -91.51%. That is a compound annual growth rate of -67.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 24.41B | -55.18% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 67.14T |
| Celltrion | 43.38T |
| ALTEOGEN | 14.86T |
| Samsung Epis Holdings | 7.59T |
| IMB Dx | 32.87B |
| HASS Corp. | 31.52B |
| BCWORLD PHARM. | 28.72B |
| LabGenomics | 26.90B |